Jana Partners’s Bristol-Myers Squibb BMY Stock Holding History

Jana Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-716,389	Closed	-$39M	–	51
2017 Q1	$39M	Sell	716,389 -3,155,872	-81%	-$173M	0.72%	29
2016 Q4	$226M	Buy	+3,872,261	New	+$212M	3.97%	8

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jana Partners's BMY Position: Q2 2017 in Review

Jana Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 716,389 shares — an estimated $39M sold.

Jana Partners first reported a position in BMY in Q4 2016 and held it in 2 quarters. The position peaked at $226M in Q4 2016. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Jana Partners reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
Jana Partners sold 716,389 Bristol-Myers Squibb shares in Q2 2017, an estimated $39M.
Jana Partners first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 2 quarters.
Jana Partners's Bristol-Myers Squibb position peaked at $226M in Q4 2016.
1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Jana Partners's 13F filing for Q2 2017, filed 14 Aug 2017.